Dr. Jan-Uwe Claas
AeroLeads people directory · profile

Dr. Jan-Uwe Claas Email & Phone Number

Chief Executive Officer at PROVIREX Genome Editing Therapies GmbH
Location: Oestrich-Winkel, Hesse, Germany 20 work roles 4 schools
LinkedIn matched
✓ Verified August 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Chief Executive Officer
Location
Oestrich-Winkel, Hesse, Germany
Company size

Who is Dr. Jan-Uwe Claas? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Dr. Jan-Uwe Claas is listed as Chief Executive Officer at PROVIREX Genome Editing Therapies GmbH, a with 11 employees, based in Oestrich-Winkel, Hesse, Germany. AeroLeads shows a matched LinkedIn profile for Dr. Jan-Uwe Claas.

Dr. Jan-Uwe Claas previously worked as Founder at Dr. Claas Consulting Gmbh and Expert Coach Healthcare & Mentor Entrepreneurship Program GeneNovate at Xplore By Unternehmertum. Dr. Jan-Uwe Claas holds Certification, International Directors Program from Insead.

Company email context

Email format at PROVIREX Genome Editing Therapies GmbH

This section adds company-level context without repeating Dr. Jan-Uwe Claas's masked contact details.

PROVIREX Genome Editing Therapies GmbH

Review company-level records connected to Dr. Jan-Uwe Claas before choosing the right outreach path.

Profile bio

About Dr. Jan-Uwe Claas

I have more than 25 years of experience in Biotech, Medtech & Pharma industry covering a broad spectrum from Pre-clinical Research to Head International Marketing (SVP) & General Management. My key strengths are the highly success­ful launch of innovative brands on a national & international level to drive company growth & profitability as well as the leadership of complex organizations with proven success.My vast international experience is based on a more than 5-years GM position in UK, more than 4-years regional GM-EU role and a 6-years collaboration with an US based global player (Johnson & Johnson).I founded Dr. Claas Consulting in 02/22. Dr. Claas Consulting offers consultancy support for start-up and established business that intends to launch brands in Germany & Europe. My support can be project-based with a focus on strategy and operative implementation or as Interim-Manager (CEO, CCO, GM, Head Marketing). More information under: claas-consulting.com

Current workplace

Dr. Jan-Uwe Claas's current company

Company context helps verify the profile and gives searchers a useful next step.

PROVIREX Genome Editing Therapies GmbH
Provirex Genome Editing Therapies Gmbh
Chief Executive Officer
Oestrich-Winkel, HE, DE
Website
Employees
11
AeroLeads page
20 roles

Dr. Jan-Uwe Claas work experience

A career timeline built from the work history available for this profile.

Founder

Current

Oestrich-Winkel, Hessen, Deutschland

Dr. Claas Consulting supports Start-Up enterprises intending to set up new commercial business in European countries as well as companies with already established business, that intends to launch or re-launch brands in Europe. The support can be…- Project-based with a focus on strategy and/or operative implementation- Interim-Management based (CEO, CCO, GM)The specific benefits of Dr. Claas Consulting are the…- Broad range from strategy to implementation- Focus on optimized & targeted investment- Implementation oriented approach based on in-depth practical experience- 360-degree view across all functions

Feb 2022 - Present

Expert Coach Healthcare & Mentor Entrepreneurship Program Genenovate

Current

Metropolregion München & Mainz

UnternehmerTUM’s pre-Incubation Program XPLORE supports founders with tech-based start-up project to prepare you for incubation and the acquisition of pre-seed capitalGeneNovate: Empowering Innovators and Entrepreneurs in Gene and Cell Therapies

Jun 2022 - Present

Special Advisor To The Board Of Directors

Current

Dublin, Grafschaft Dublin, Irland

Kora Healthcare is a fully integrated healthcare company with core competencies across Research, Development & Innovation, Scientific & Medical Affairs, Regulatory Affairs & Pharmacovigilance, Quality, Supply Chain, Marketing & Sales, Finance and Customer Services.

Jul 2024 - Present

Senior Consultant & Lead Facilitator

Current

Metropolregion San Francisco Bay Area

As a senior consultant and lead facilitator, I lead a variety of learning programs like Healthcare Economics, Market Access, Healthcare Compliance, GxP & Drug Development that help advance capabilities from early on in career through executive leadership with a focus on the Health Care Industry. Based on my 30 years of experience in Health Care & Pharma I support professionals especially in the US Biotech industry to further develop their capabilities and skill-sets.

Apr 2023 - Present

Business Angel

Current
Startup In Stealth Mode

Berlin, Deutschland

Startup in stealth mode (Biotechnology)

Jun 2024 - Present

Partner

Current

Germany

Each partner in the network has outstanding skills and has qualified in an intensive selection process to become a member. Practical experience is our strength. The partners of Healthcare Shapers are consultants with many years of practical experience in the healthcare industry. Our diversity promotes unconventional ideas, creating new insights and approaches.

Mar 2022 - Present

Interim Head Of Marketing

Support the private equity funded international pharmaceutical company NEURAXPHARM in the transformation from generic business to provider of innovative brands.Successful launch of the new Anti-CD20 Antibody BRIUMVI for Multiple Sclerosis in the highly competitive German MS market.

Jun 2023 - May 2024

General Manager Country Cluster Europe

Kreisfreie Stadt Aachen Und Umgebung, Deutschland

General Manager responsible for the Country Cluster Europe Organization consisting of Portugal, Switzerland, Austria, Belgium, Luxembourg, Netherlands, Ireland, Sweden, Denmark, Norway and Finland. Full P&L responsibility. Key achievements after setting up the new organisational structure with 250 employees:Doubling the profit margin within 3 years, from 25 % in 2017 to 50 % in 2020. Key focus: Implement measures to improve team culture & quality of leadership and establish new governance structure & processes to foster cross-functional working.

Aug 2017 - Feb 2022

Head Marketing Europe (Senior Vice President)

Kreisfreie Stadt Aachen Und Umgebung, Deutschland

Jan 2017 - Aug 2017

General Manager United Kingdom & Ireland

Stokenchurch Uk

180 employees, full P&L responsibilityIncrease of UK Profit Margin from -23 % in 2011 to +38% in 2016 due to sales growth of innovations, focussed investment and improved quality of services. Establish Grϋnenthal UK as the key player in the pain market by introducing innovative customer services. Key focus: Close cooperation & alignment of all departments/teams, up-skilling of customer facing teams & improvement of market access.Appointed member of the ABPI (Association of the British Pharmaceutical Industry) Board of Directors. Grünenthal Best Performance Award 2013 for UK turnaround.

Oct 2011 - Jan 2017

Senior Vice President Marketing Europe & Australia

Aachen, Germany

Responsible for all innovative Grϋnenthal brands incl. brand communication, E-marketing and scientific marketing. Launch of Grϋnenthal's priority innovation (Palexia) across Europe and implementation of non-branded educational initiative in all EU countries (2015 EU sales >150 Mio €/ strong growth), Team size: 21 employees

Sep 2010 - Oct 2011

Vice President Global Marketing

Aachen, Germany

Global launch of new innovation (Palexia) from Grϋnenthal laboratories in cooperation with J&J. Responsible for Brand Communication, Scientific Marketing, Life Cycle Management and launch of global educational initiative together with international scientific societies and experts (CHANGE PAIN).

May 2009 - Aug 2010

Head Of Global Marketing Narcotic Analgesics

Aachen , Germany

Global marketing responsibility for all strong analgesics. Pre-launch preparation for global launch of new innovation (Palexia) from Grϋnenthal laboratories (1st new centrally acting analgesic in 25 years) in cooperation with J&J

Nov 2007 - Apr 2009

Global Commercial Lead New Analgesics

Aachen, Germany

Responsible for global commercial development of all new molecules invented by Grϋnenthal: Commercial responsibility in international partnering processesCommercial lead in global cooperation with J&J from clinical phase 2b into post launchCommercial lead in 2 year project to assess US market presence via payer, prescriber & patient research

Sep 2004 - Oct 2007

Head Of Marketing Germany

Aachen, Germany

Responsible for marketing team (5-8 reports) and marketing budget (9 Mio €)Launch of new analgesic, monthly sales of 3,7 Mio € in 08/2004Introduction of new educational workshop program: 10.000 physicians p.a.

Feb 2002 - Aug 2004

Head Of Medical Marketing Oncology

Neuss, Germany

Responsible for Key opinion leader management and Investigator Initiated Studies in GermanyDevelopment of scientifc communication strategy later implemented across Europe

Jan 1998 - Dec 1999
4 education records

Dr. Jan-Uwe Claas education

Certification, International Directors Program

Value Creation for Directors to develop the skills and knowledge for highly effective board membership. Focus is on key areas of value.

Organizational Consultant - Organisationsentwickler

Der Berufsverband Für Training, Beratung Und Coaching (Bdvt) - Institut Für Persönlichkeit

Study and implementation of practices, systems and techniques that affect organizational change in order to improve an organisation's.

Dr. Rer. Nat. (Phd), Microbiology, Biochemistry, Organic Chemistry, Magna Cum Laude

Doctoral thesis at the scientific laboratories of Boehringer Mannheim in cancer research & immunology. Title: "Pharmakologische.

FAQ

Frequently asked questions about Dr. Jan-Uwe Claas

Quick answers generated from the profile data available on this page.

What company does Dr. Jan-Uwe Claas work for?

Dr. Jan-Uwe Claas works for PROVIREX Genome Editing Therapies GmbH.

What is Dr. Jan-Uwe Claas's role at PROVIREX Genome Editing Therapies GmbH?

Dr. Jan-Uwe Claas is listed as Chief Executive Officer at PROVIREX Genome Editing Therapies GmbH.

Where is Dr. Jan-Uwe Claas based?

Dr. Jan-Uwe Claas is based in Oestrich-Winkel, Hesse, Germany while working with PROVIREX Genome Editing Therapies GmbH.

What companies has Dr. Jan-Uwe Claas worked for?

Dr. Jan-Uwe Claas has worked for Provirex Genome Editing Therapies Gmbh, Dr. Claas Consulting Gmbh, Xplore By Unternehmertum, Kora Healthcare, and Hands On L&D.

How can I contact Dr. Jan-Uwe Claas?

You can use AeroLeads to view verified contact signals for Dr. Jan-Uwe Claas at PROVIREX Genome Editing Therapies GmbH, including work email, phone, and LinkedIn data when available.

What schools did Dr. Jan-Uwe Claas attend?

Dr. Jan-Uwe Claas holds Certification, International Directors Program from Insead.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.